Zolmitriptan (Systemic)

Brand Names : Zomig

Before Using This Medicine

In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For zolmitriptan, the following should be considered:

Allergies - Tell your doctor if you have ever had any unusual or allergic reaction to zolmitriptan. Also tell your health care professional if you are allergic to any other substances, such as foods, preservatives, or dyes.

Pregnancy - Zolmitriptan has not been studied in pregnant women. However, in some animal studies, zolmitriptan caused harmful effects to the fetus. These unwanted effects usually occurred when zolmitriptan was given in amounts that were large enough to cause harmful effects in the mother.

Breast-feeding - Although most medicines pass into breast milk in small amounts, many of them may be used safely while breast-feeding. Mothers who are taking this medicine and who wish to breast-feed should discuss this with their doctor.

Children - There is no specific information comparing use of zolmitriptan in children with use in other age groups.

Adolescents - There is no specific information comparing use of zolmitriptan in teenagers with use in other age groups.

Older adults - There is no specific information comparing use of zolmitriptan in patients older than 65 years of age with use in younger adults.

Other medicines - Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. Tell your health care professional if you are taking any other prescription or nonprescription (over-the-counter [OTC]) medicine, especially other prescription medicine for migraine headaches, or if you smoke tobacco.

When you are taking zolmitriptan, it is especially important that your health care professional know if you are taking the following:

• Monoamine oxidase-A (MAO-A) inhibitor activity (isocarboxazid [e.g., Marplan], phenelzine [e.g., Nardil], procarbazine [e.g., Matulane], selegiline [e.g., Eldepryl], tranylcypromine [e.g., Parnate]) - Taking zolmitriptan while you are taking or within 2 weeks of taking MAO inhibitors may cause sudden high body temperature, extremely high blood pressure, and severe convulsions; at least 14 days should be allowed between stopping treatment with one medicine and starting treatment with the other.

Other medical problems - The presence of other medical problems may affect the use of zolmitriptan. Make sure you tell your doctor if you have any other medical problems, especially:

• Angina (chest pain) or
• Fast or irregular heartbeat or
• Heart or blood vessel disease or
• High blood pressure or
• Kidney disease or
• Liver disease or
• Stroke (history of) - The chance of side effects may be increased. Heart or blood vessel disease and high blood pressure sometimes do not cause any symptoms, so some people do not know that they have these problems. Before deciding whether you should use zolmitriptan, your doctor may need to do some tests to make sure that you do not have any of these conditions.

• Phenylketonuria (PKU) - The oral disintegrating tablets may contain aspartame, which can make your condition worse